Kadimastem: Hadassah approvals IRB for conducting a clinical trial in ALS Patients

Israeli biotechnology company Kadimastem has received approval from the IRB (Helsinki Committee) of the Hadassah Ein Kerem Hospital for the phase I/IIa clinical trial...

Read more

Israeli researchers propose link between gluten and ALS

Team from Tel Aviv Sourasky Medical Center believes sensitivity to gluten experienced by people with celiac disease could cause a syndrome that looks like Lou...

Read more

Israël Science Info